Cost analysis of the Spanish renal replacement therapy programme

Background. A cost analysis of the Spanish Renal Replacement Therapy (RRT) programme in the year 2010, for end-stage renal disease (ESRD) patients, was performed from the perspective of the Public Administration. Methods. The costs associated with each RRT modality [hemodialysis (HD), peritoneal dialysis (PD) and kidney transplantation (Tx)] were analysed. The Spanish ESRD incidence and prevalence figures in the year 2010 were forecasted in order to enable the calculation of an aggregate cost for each modality. Costs were mainly computed based on a review of the existing literature and of the Official Bulletins of the Spanish Autonomous Communities. Data from Oblikue Consulting eSalud health care costs database and from several Spanish public sources were also employed. Results. In the year 2010, the forecasted incidence figures for HD, PD and Tx were 5409, 822 and 2317 patients, respectively. The forecasted prevalence figures were 22 582, 2420 and 24 761 patients, respectively. The average annual per-patient costs (incidence and prevalence) were (sic)2651 and (sic)37 968 (HD), (sic)1808 and (sic)25 826 (PD) and (sic)38 313 and (sic)6283 (Tx). Indirect costs amounted to (sic)8929 (HD), (sic)7429 (PD) and (sic)5483 (Tx). The economic impact of the Spanish RRT programme on the Public Administration budget was estimated at similar to(sic)1829 million (indirect costs included): (sic)1327 (HD), (sic)109 (PD) and (sic)393 (Tx) million. Conclusions. HD accounted for > 70% of the aggregate costs of the Spanish RRT programme in 2010. From a costs minimization perspective, it would be preferable if the number of incident and prevalent patients in PD were increased.